Tissue Regenix Group (TRX)

Sector:

Financials

Index:

FTSE AIM All-Share

26.67p
   
  • Change Today:
    -0.93p
  • 52 Week High: 74.00
  • 52 Week Low: 26.50
  • Currency: UK Pounds
  • Shares Issued: 71.40m
  • Volume: 2,708
  • Market Cap: £19.04m
  • RiskGrade: 22
  • Beta: 0.00

Latest Deals

No deals were found in the last 365 days.

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

TRX Market Data

Currency UK Pounds
Share Price 26.67p
Change Today -0.93p
% Change -3.38 %
52 Week High 74.00
52 Week Low 26.50
Volume 2,708
Shares Issued 71.40m
Market Cap £19.04m
Beta 0.00
RiskGrade 22

TRX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.21% below the market average0.21% below the market average0.21% below the market average0.21% below the market average0.21% below the market average
8% below the sector average8% below the sector average8% below the sector average8% below the sector average8% below the sector average
Price Trend
85.72% below the market average85.72% below the market average85.72% below the market average85.72% below the market average85.72% below the market average
86.41% below the sector average86.41% below the sector average86.41% below the sector average86.41% below the sector average86.41% below the sector average
Income Not Available
Growth
12.35% above the market average12.35% above the market average12.35% above the market average12.35% above the market average12.35% above the market average
3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average

TRX Dividends

No dividends found

Trades for 14-Jul-2025

Time Volume / Share Price
11:54 1,886 @ 26.50p
08:00 822 @ 26.50p

TRX Key Personnel

CEO Daniel Lee
CFO David Cocke

Top of Page